Janus Henderson Global Life Sciences Fund Class I (JFNIX)
| Fund Assets | 5.28B |
| Expense Ratio | 0.77% |
| Min. Investment | $1,000,000 |
| Turnover | 30.00% |
| Dividend (ttm) | 3.71 |
| Dividend Yield | 4.53% |
| Dividend Growth | -7.24% |
| Payout Frequency | Annual |
| Ex-Dividend Date | Dec 5, 2025 |
| Previous Close | 81.92 |
| YTD Return | 0.41% |
| 1-Year Return | 33.72% |
| 5-Year Return | 44.41% |
| 52-Week Low | 64.42 |
| 52-Week High | 85.21 |
| Beta (5Y) | n/a |
| Holdings | 104 |
| Inception Date | Jul 6, 2009 |
About JFNIX
Janus Henderson Global Life Sciences Fund Class I is an open-end mutual fund specializing in global equities within the life sciences sector. Its primary objective is to achieve long-term capital growth by investing at least 80% of its assets in companies with a life sciences orientation, spanning industries such as biotechnology, pharmaceuticals, medical devices, and health care services. The fund pursues a diversified, actively managed approach, allocating assets across various market capitalizations and geographies, including up to 20% in developing markets. With a focus on addressing unmet medical needs and enhancing health care system efficiency, portfolio holdings typically include prominent global health care companies. The fund’s management team employs rigorous fundamental research and risk management processes to construct a balanced portfolio. It benchmarks its performance mainly against the MSCI World Health Care Index, aiming to outperform the index by 2% per annum over a rolling five-year period. The fund is designed for institutional investors, offering a competitive expense ratio and leveraging the expertise of a specialized investment team with deep domain knowledge in health care innovation.
Performance
JFNIX had a total return of 33.72% in the past year, including dividends. Since the fund's inception, the average annual return has been 14.94%.
Top 10 Holdings
40.51% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 8.84% |
| Johnson & Johnson | JNJ | 7.29% |
| AstraZeneca PLC | AZN | 4.59% |
| AbbVie Inc. | ABBV | 4.05% |
| UnitedHealth Group Incorporated | UNH | 3.13% |
| Novartis AG | NVS | 2.86% |
| Thermo Fisher Scientific Inc. | TMO | 2.51% |
| Praxis Precision Medicines, Inc. | PRAX | 2.45% |
| argenx SE | ARGX | 2.40% |
| Abbott Laboratories | ABT | 2.40% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 5, 2025 | $3.71003 | Dec 5, 2025 |
| Dec 6, 2024 | $3.99969 | Dec 6, 2024 |
| Dec 7, 2023 | $2.96525 | Dec 7, 2023 |
| Dec 20, 2022 | $0.20212 | Dec 20, 2022 |
| Dec 20, 2021 | $6.8555 | Dec 20, 2021 |
| Dec 17, 2020 | $5.6057 | Dec 17, 2020 |